The main goal of this work is to support automated seizure prediction by identifying preictal states using multiple detectors of high-frequency oscillations (HFOs). Assessment of HFOs from a seizure onset zone may be facilitated using automatic HFO detectors. However, studies have shown that HFOs can be generated by physiological or pathological brain processes. Distinguishing between pathological and physiological HFOs is challenging due to a lack of discriminant information in signals’ morphology and other characteristics. Other complicating factors include a lack of consistency in definitions of HFO frequency ranges, the need for expert verification of HFO detection, and lack of robustness of automatic HFO detectors. In addition, artifac...
High-frequency oscillations (HFOs, ripples: 80-200 Hz, fast ripples: 250-500 Hz) recorded from the e...
<div><p>High-frequency oscillations (HFO) have been suggested as biomarkers of epileptic tissues. Wh...
There is a need for novel biomarkers to aid in the clinical treatment of epilepsy and improve the un...
The main goal of this work is to support automated seizure prediction by identifying preictal states...
Attempts to perform epileptic seizure prediction have been made for decades, but there is no solutio...
Attempts to perform epileptic seizure prediction have been made for decades, but there is no solutio...
OBJECTIVES: High frequency oscillations (HFOs) have been proposed as a new biomarker for epileptogen...
High frequency oscillations (HFOs) have been proposed as a new biomarker for epileptogenic tissue. T...
OBJECTIVES: High frequency oscillations (HFOs) have been proposed as a new biomarker for epileptogen...
International audienceGoal: Interictal high-frequency oscillations (HFOs [30-600 Hz]) have proven to...
Seizure prediction is a decades-old research problem that has yet to reach any satisfying conclusion...
High frequency oscillations (HFOs) are a promising biomarker of epileptic tissue, but detection of t...
International audienceInterictal High Frequency Oscillations, (HFOs [30-600 Hz]), recorded from intr...
Epilepsy is a chronic neurological disorder characterized by seizures. Although most patients respon...
High-frequency oscillations (HFO) have been suggested as biomarkers of epileptic tissues. While visu...
High-frequency oscillations (HFOs, ripples: 80-200 Hz, fast ripples: 250-500 Hz) recorded from the e...
<div><p>High-frequency oscillations (HFO) have been suggested as biomarkers of epileptic tissues. Wh...
There is a need for novel biomarkers to aid in the clinical treatment of epilepsy and improve the un...
The main goal of this work is to support automated seizure prediction by identifying preictal states...
Attempts to perform epileptic seizure prediction have been made for decades, but there is no solutio...
Attempts to perform epileptic seizure prediction have been made for decades, but there is no solutio...
OBJECTIVES: High frequency oscillations (HFOs) have been proposed as a new biomarker for epileptogen...
High frequency oscillations (HFOs) have been proposed as a new biomarker for epileptogenic tissue. T...
OBJECTIVES: High frequency oscillations (HFOs) have been proposed as a new biomarker for epileptogen...
International audienceGoal: Interictal high-frequency oscillations (HFOs [30-600 Hz]) have proven to...
Seizure prediction is a decades-old research problem that has yet to reach any satisfying conclusion...
High frequency oscillations (HFOs) are a promising biomarker of epileptic tissue, but detection of t...
International audienceInterictal High Frequency Oscillations, (HFOs [30-600 Hz]), recorded from intr...
Epilepsy is a chronic neurological disorder characterized by seizures. Although most patients respon...
High-frequency oscillations (HFO) have been suggested as biomarkers of epileptic tissues. While visu...
High-frequency oscillations (HFOs, ripples: 80-200 Hz, fast ripples: 250-500 Hz) recorded from the e...
<div><p>High-frequency oscillations (HFO) have been suggested as biomarkers of epileptic tissues. Wh...
There is a need for novel biomarkers to aid in the clinical treatment of epilepsy and improve the un...